Trulieve Cannabis Corp. (TRLV) Stock Price

TRLVStock

$10.01+236.11%52W

Market Cap$1.93B

P/E—

PEG Ratio—

Div yield—

Beta0.38

TRLV Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)99.95%

Price vs S&P 500 (4W)-11.63%

VGM Score66.17

P/CF (Annual)7.07x

Book Value / Share (Quarterly)$3.99

P/TBV (Annual)2.02x

Revenue Growth (3Y)-1.60%

Cash Flow / Share (Quarterly)$0.97

Price vs S&P 500 (YTD)-18.17%

Gross Margin (TTM)59.47%

Net Profit Margin (TTM)-41.55%

EPS (TTM)$-2.46

10-Day Avg Trading Volume1.37M

EPS Excl Extra (TTM)$-2.46

Revenue Growth (5Y)17.76%

EPS (Annual)$-0.61

ROI (Annual)-8.80%

Gross Margin (Annual)60.21%

Net Profit Margin (5Y Avg)-17.50%

Cash / Share (Quarterly)$1.69

Revenue Growth QoQ (YoY)-10.31%

ROA (Last FY)-7.24%

Revenue Growth TTM (YoY)-3.90%

EBITD / Share (TTM)$-0.85

ROE (5Y Avg)13.78%

Operating Margin (TTM)-24.49%

Cash Flow / Share (Annual)$-0.89

P/B Ratio2.51x

P/B Ratio (Quarterly)2.46x

Net Income / Employee (Annual)$-23,300

EV / Revenue (TTM)2.30x

Net Interest Coverage (TTM)2.87x

ROA (TTM)-18.04%

EV / EBITDA (TTM)10.25x

EPS Incl Extra (Annual)$-0.61

Current Ratio (Annual)2.82x

Quick Ratio (Quarterly)3.76x

3-Month Avg Trading Volume1.66M

52-Week Price Return236.11%

EV / Free Cash Flow (Annual)9.81x

Revenue / Employee (TTM)$227,800

Tangible BV / Share (Quarterly)$2.43

P/S Ratio (Annual)1.63x

Asset Turnover (Annual)0.36x

52-Week High$12.93

Operating Margin (5Y Avg)5.01%

EPS Excl Extra (Annual)$-0.61

CapEx CAGR (5Y)-15.68%

26-Week Price Return108.62%

Quick Ratio (Annual)1.21x

13-Week Price Return13.88%

Total Debt / Equity (Annual)0.45x

Current Ratio (Quarterly)5.94x

Enterprise Value$2.08B

Revenue / Share Growth (5Y)6.97%

Asset Turnover (TTM)0.43x

Revenue / Employee (Annual)$236,200

Inventory Turnover (Annual)2.23x

Pretax Margin (Annual)7.74%

Cash / Share (Annual)$1.11

3-Month Return Std Dev56.08%

Gross Margin (5Y Avg)57.99%

Net Income / Employee (TTM)$-94,700

EBITDA CAGR (5Y)2.36%

EBITDA Interim CAGR (5Y)-3.44%

ROE (Last FY)-12.74%

Net Interest Coverage (Annual)-6.00x

EPS Basic Excl Extra (Annual)$-0.61

P/FCF (TTM)10.33x

Receivables Turnover (TTM)154.98x

EV / Free Cash Flow (TTM)11.16x

Total Debt / Equity (Quarterly)0.63x

EPS Incl Extra (TTM)$-2.46

Receivables Turnover (Annual)164.21x

ROI (TTM)-29.47%

P/S Ratio (TTM)1.69x

Pretax Margin (5Y Avg)0.07%

Revenue / Share (Annual)$6.17

Tangible BV / Share (Annual)$5.09

Forward P/E51.29x

Price vs S&P 500 (52W)212.73%

Year-to-Date Return-12.96%

5-Day Price Return-3.66%

EPS Normalized (Annual)$-0.61

ROA (5Y Avg)6.40%

Net Profit Margin (Annual)-9.85%

Month-to-Date Return-8.17%

EBITD / Share (Annual)$1.36

Operating Margin (Annual)12.00%

LT Debt / Equity (Annual)0.40x

P/CF (TTM)7.87x

ROI (5Y Avg)10.08%

LT Debt / Equity (Quarterly)0.37x

EPS Basic Excl Extra (TTM)$-2.46

P/TBV (Quarterly)4.05x

P/B Ratio (Annual)0.99x

Inventory Turnover (TTM)2.16x

Pretax Margin (TTM)-28.61%

Book Value / Share (Annual)$10.38

Price vs S&P 500 (13W)11.19%

Beta0.38x

P/FCF (Annual)9.08x

Revenue / Share (TTM)$5.91

ROE (TTM)-44.03%

52-Week Low$7.82

vGradeB

gGradeC

mGradeA

vgmGradeB

TRLV Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 7, 2026	$0.03	$0.11	+266.67%(+$0.08)
Q1 2026	May 7, 2026	-$0.05	$0.10	+300.00%(+$0.15)
Q4 2025	Feb 26, 2026	-$0.03	-$0.02	+31.03%(+$0.01)
Q3 2025	Nov 5, 2025	-$0.07	-$0.07	-3.32%(-$0.00)
Q2 2025	Aug 6, 2025	-$0.05	-$0.04	+24.17%(+$0.01)

TRLV Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.08

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
TRLVTrulieve Cannabis Corp.	B	C	A	1.7x	-3.9%	59.5%	—	$10.01
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	B	—	—	—	—	$9.59
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	B	—	—	—	—	$32.10
CRONCronos Group Inc. Common Share	C	B	A	6.6x	37.5%	46.5%	-50.0%	$3.21
TLRYTilray Brands, Inc. Common Stock	B	B	D	0.5x	15.9%	29.1%	—	$3.04
CGCCanopy Growth Corporation Common Shares	B	C	D	1.6x	6.8%	28.5%	—	$0.71
SNDLSundial Growers Inc. Common Shares	B	C	B	0.5x	-1.7%	26.2%	—	$1.25
GLASGlass House Brands Inc.	B	C	D	1.2x	-25.6%	30.8%	—	$3.19
USNAUSANA Health Sciences Inc	B	D	C	0.3x	5.7%	77.5%	-37.0%	$15.54
ACBAurora Cannabis Inc. Common Shares	B	D	B	1.3x	-18.9%	6.3%	—	$3.99
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	1.5x	11.0%	64.2%	—	$2.49
MDWDMediWound Ltd.	D	F	C	12.9x	-40.3%	15.5%	—	$11.85
FTLFFitLife Brands, Inc. Common Stock	B	C	C	0.8x	17.0%	36.5%	-20.0%	$8.39
BTMDBiote Corp. Class A Common Stock	A	D	D	0.2x	-7.8%	68.6%	-26.8%	$1.08
MTEXMannatech Inc.	B	D	B	0.1x	-5.0%	76.1%	-0.8%	$7.13
BONBon Natural Life Limited Class A Ordinary Shares	A	D	C	0.5x	-12.9%	22.1%	—	$1.14
NAIINatural Alternatives International Inc.	A	C	D	0.1x	9.8%	6.3%	—	$1.15
AKANAkanda Corp. Common Shares	C	F	F	12.2x	-63.1%	-60.5%	—	$1.20
IMCCIM Cannabis Corp. Common Shares	A	B	F	0.1x	12.7%	18.6%	—	$1.39
SNYRSynergy CHC Corp. Common Stock	A	C	F	0.0x	8.3%	65.4%	118.4%	$0.03
MEHAFunctional Brands, Inc. Common Stock	A	C	C	0.0x	—	53.7%	—	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	B	—	—	—	—	$23.11

About Trulieve Cannabis Corp.

Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.